Technical Description
The invention presents a biocompatible, stable 3D hydrogel formulation for sustained release of therapeutic molecules, aimed at managing neurodegeneration, along with its synthesis method.
Problems Addressed
- Lack of Targeted Effect
- Low Half-Life
- Heat Sensitivity
- Neurological Oversight
Tech Features
- 3D Hydrogel-Based Formulation
- Controlled Delivery
- Blood-Brain Permeability
- Fibrosis Escape
- Host Immune Reaction
- Optimized Targeting
Target Audience
- Pharmaceutical Industry
- Biotechnology Sector
- Healthcare
- Research & Development
Tech ID: P35-2277 TRL 4 Patent Status: Published Available For Exclusive and Non-exclusive License
